• 
  Léa Dépéry, Isabelle Bally, Axelle Amen, Benjamin Némoz, Marlyse Buisson, et al.. Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants. Microbiology Spectrum, 2024, 2024, pp.e0156824. ⟨10.1128/spectrum.01568-24⟩. ⟨hal-04795491⟩
• 
  Jean-Mathieu Desveaux, Eric Faudry, Carlos Contreras-Martel, François Cretin, Leonardo Sebastian Dergan-Dylon, et al.. Protective human monoclonal antibodies that target the Type III Secretion System of Pseudomonas aeruginosa inhibit translocon function. 2024. ⟨hal-04763662⟩
• 
  Doriane Delafosse. Contributions des principales étapes du traitement des eaux usées à l’abattement des charges en virus entériques humains : approche des mécanismes mis en jeu. Ecologie, Environnement. Université Grenoble Alpes [2020-..], 2024. Français. ⟨NNT : 2024GRALV019⟩. ⟨tel-04730735⟩
• 
  Axelle Amen, Randy Yoo, Amanda Fabra-García, Judith Bolscher, William J. R. Stone, et al.. Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross stage recognition of glutamate-rich repeats. eLife, In press, ⟨10.7554/eLife.97865.2⟩. ⟨hal-04717738⟩
• 
  Maya Hites, Clément Massonnaud, Eva Larranaga Lapique, Drifa Belhadi, Simon Jamard, et al.. Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial. Journal of Infection, 2024, 88 (3), pp.106120. ⟨10.1016/j.jinf.2024.106120⟩. ⟨hal-04577427⟩

71

76